Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015-Reference-Cited by-同舟云学术

Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015

Published:2018-09-01 Issue:9 Volume:3 Page:865
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Alexander Kevin M.¹,Orav John²,Singh Avinainder¹,Jacob Sophia A.³⁴⁵⁶⁷,Menon Adil³⁴⁵⁶⁷,Padera Robert F.⁸,Kijewski Marie F.³⁴⁵⁶⁷,Liao Ronglih¹,Di Carli Marcelo F.³⁴⁵⁶⁷,Laubach Jacob P.⁹,Falk Rodney H.¹,Dorbala Sharmila¹³⁴⁵⁶

Affiliation:

1. Cardiac Amyloidosis Program, Division of Cardiology, Department of Medicine, Heart & Vascular Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

2. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

3. Cardiovascular Imaging Program, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

4. Departments of Medicine and Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

5. Division of Nuclear Medicine and Molecular Imaging, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

6. Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

7. Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

8. Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

9. Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. The systemic amyloidoses.;Falk;N Engl J Med,1997

2. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.;Dubrey;QJM,1998

3. Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: a prospective, observational cohort study.;Connors;Circulation,2016

4. Novel pharmacotherapies for cardiac amyloidosis.;Alexander;Pharmacol Ther,2017

5. Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment.;Gertz;Am J Hematol,2016

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects;Seminars in Nuclear Medicine;2024-09

2. Causes of Death and Mortality Trends in Individuals with Thalassemia in the United States, 1999-2020;Journal of Blood Medicine;2024-08

3. Recent advances in the diagnostic methods and therapeutic strategies of transthyretin cardiac amyloidosis;World Journal of Cardiology;2024-07-26

4. Non-Hodgkin lymphoma mortality disparities across different sexes, races, and geographic locations;Journal of Investigative Medicine;2024-07-24

5. Effect of dynamic exclusion and the use of FAIMS, DIA and MALDI-mass spectrometry imaging with ion mobility on amyloid protein identification;Clinical Proteomics;2024-07-03